These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8309594)

  • 21. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?
    Sorensen JC; Cheregi BD; Timpani CA; Nurgali K; Hayes A; Rybalka E
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):673-83. PubMed ID: 27167634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
    Till M; MacDonell KB
    Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
    [No Abstract]   [Full Text] [Related]  

  • 26. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P; Ruet E; Gherardi R
    Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
    [No Abstract]   [Full Text] [Related]  

  • 27. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
    Gherardi RK; Florea-Strat A; Fromont G; Poron F; Sabourin JC; Authier J
    Ann Neurol; 1994 Nov; 36(5):752-8. PubMed ID: 7979221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 32. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blepharoptosis and HAART related mitochondrial myopathy.
    Chapman KO; Lelli G
    Orbit; 2014 Dec; 33(6):459-61. PubMed ID: 25215893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
    Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
    Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
    Semino-Mora MC; Leon-Monzon ME; Dalakas MC
    Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
    Weisser M
    Praxis (Bern 1994); 1997 Oct; 86(43):1708-10. PubMed ID: 9432697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria (author's transl)].
    Okamura K; Nagae K; Omae T; Mita T
    Rinsho Shinkeigaku; 1975 Apr; 15(4):177-83. PubMed ID: 1170056
    [No Abstract]   [Full Text] [Related]  

  • 38. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.
    Lewis W; Gonzalez B; Chomyn A; Papoian T
    J Clin Invest; 1992 Apr; 89(4):1354-60. PubMed ID: 1556193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy.
    Campos Y; Arenas J
    Ann Neurol; 1994 Oct; 36(4):680-1. PubMed ID: 7944307
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.